News | Magnetic Resonance Imaging (MRI) | April 27, 2017

GE Healthcare Highlights New Signa Premier MRI System at ISMRM 2017

System is now FDA 510(k) pending

GE Healthcare Highlights New Signa Premier MRI System at ISMRM 2017

April 27, 2017 — GE Healthcare will showcase Signa Premier, its U.S. Food and Drug Administration (FDA) 510(k)-pending, wide bore 3.0T magnetic resonance imaging (MRI) system at the 25th International Society of Magnetic Resonance Imaging (ISMRM) Annual Meeting, April 22-27 in Honolulu, Hawaii.

Signa Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world working to design new imaging tools. The new MRI system delivers a high performance with research-focused clinical capabilities designed particularly for neurological and oncology research and clinical work.

“The image quality we have seen to date from the Signa Premier is excellent and very consistent,” said Scott Reeder, M.D., Ph.D., vice chair of research and chief of MRI at University of Wisconsin-Madison (UW-Madison). UW-Madison, one of GE Healthcare’s top collaborators, is testing a research system of Signa Premier and has scanned approximately 100 subjects to date. “The high-fidelity gradients and RF systems of a scanner are key to obtaining high-quality, repeatable and reproducible quantitative measurements; this is increasingly important as we move from qualitative to quantitative imaging. Signa Premier combines the advantages of a wide bore system with an ultra-high-performance system and in some instances, is outperforming other ultra-high-performance systems with smaller bore sizes, particularly for diffusion-weighted applications. I believe the wide bore is going to improve access and comfort for patients at our hospital. We have also been able to improve the spatial resolution with very similar SNR performance as other ultra-high-performance systems,” said Reeder

This system is built on a platform with:

  • A short-bore, high-homogeneity magnet;
  • Powerful new gradients;
  • A new digital RF transmit and receive architecture; and
  • Cutting-edge applications, including cloud analytics.

Signa Premier is powered by SuperG gradient technology to improve diagnostic confidence for clinicians. The SuperG gradient coil introduces outstanding performance and superb stability, which is designed to deliver the performance of an ultra-high-performance, research-class 60 centimeter MRI system in a 70 centimeter bore MRI.

The RF technology of SIGNA Premier is designed to provide greater clinical performance and higher overall image quality, especially for data-intensive applications, based on GE’s Total Digital Imaging (TDI) architecture. A total of 146 independent channels allow the simultaneous combination of multiple ultra-high channel count surface coils for faster accelerations and uncompromised image clarity.

The TDI 48-channel Head Coil delivers clinical performance for virtually every patient. A fit- adaptable design addresses 99.99 percent of the population — including extremely large heads and short necks — while preserving high signal-to-noise ratio (SNR) and outstanding and sustainable image quality.

The new MRI system is based on the SignaWorks productivity platform, which is designed to improve productivity for radiologists and technologists. Signa Premier supports eight times faster productivity with HyperWorks, a new speed scanning tool. SignaWorks takes full advantage of the SuperG gradient technology and the TDI RF architecture to further advance and accelerate diagnostic outcomes, with signature applications such as MAGiC, HyperBand and HyperSense, while simultaneously improving patient throughput and ROI for clinicians. Further, the system runs on GE Healthcare’s Orchestra reconstruction platform that is now available through the company’s collaboration portal to allow researchers to compose their own reconstruction algorithms that can be easily integrated with the data acquisition on the scanner. Orchestra gives users the flexibility and potential to use the power of Signa Premier in new and innovative research.

For more information: www.gehealthcare.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...